- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BRCA
Total 508 results
-
Institut de Cancérologie de LorraineCompleted
-
Lei LiCompletedEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | Chinese | Homologous Recombination GenesChina
-
The Christie NHS Foundation TrustClinical Trials Unit, ManchesterCompleted
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
National Cancer Institute (NCI)Completed
-
University of WashingtonCompletedOvarian CancerUnited States
-
University of Texas Southwestern Medical CenterCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
Karolinska InstitutetCompletedWomen With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2Sweden
-
National Human Genome Research Institute (NHGRI)CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Washington; Sarah Lawrence CollegeCompletedBreast CancerUnited States
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedBRCA1 Gene | BRCA2 GeneUnited States
-
PfizerTerminated
-
AstraZenecaCompleted
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Finland, France, Hungary, Israel, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
-
Wales Cancer Trials UnitPierre Fabre LaboratoriesCompleted
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Istituto Oncologico di BariCompletedBreast Cancer | BRCA1 Mutation | BRCA2 Mutation | Dietary ModificationItaly
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
Massachusetts General HospitalCompletedBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
University of WashingtonAbbVieNo longer availableTriple-Negative Breast Cancer | Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic MutationUnited States
-
Jazz PharmaceuticalsCompletedColorectal NeoplasmsUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | ATR Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CHEK1 Gene Mutation | FANCA Gene... and other conditionsUnited States, Canada
-
Johns Hopkins UniversityNational Cancer Institute (NCI); Lustgarten FoundationCompletedPancreatic Neoplasm | Peutz-Jeghers SyndromeUnited States
-
AGO Research GmbHCompleted
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
PfizerTerminatedDisease ProgressionUnited States, Belgium, France, Argentina, United Kingdom
-
Dana-Farber Cancer InstituteIncyte CorporationCompletedMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Yonsei UniversityEnrolling by invitationPlatinum-sensitive Recurrent BRCA Wild Type Ovarian CancerKorea, Republic of
-
Columbia UniversityAmerican Cancer Society, Inc.CompletedBreast Cancer | Ovarian Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
Samsung Medical CenterCompleted
-
Yale UniversityCompleted
-
Chung-Ang UniversityCompletedBRCA Gene RearrangementKorea, Republic of
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | BRCA1 MutationUnited States, Austria
-
Lei LiUnknownEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum ResistanceChina
-
Seoul National University HospitalBayer; Korean Society of Breast Imaging & Korean Society For Breast ScreeningUnknownBreast Cancer | BRCA1 Mutation | BRCA2 Mutation | Recurrent Breast Cancer | Metachronous NeoplasmKorea, Republic of
-
Impact Therapeutics, Inc.Unknown
-
Rabin Medical CenterCompletedBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
Xiaoxiang ChenUnknownNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Endocrine System Diseases | Ovarian Diseases | Adnexal Diseases | Gonadal Disorders | Endocrine Gland Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms and other conditionsChina
-
AstraZenecaTerminated
-
PharmaMarCompletedBreast CancerUnited States, Spain
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationChina
-
The Netherlands Cancer InstituteRadboud University Medical Center; Erasmus Medical Center; Dutch Cancer SocietyUnknownCardiovascular Diseases | Quality of Life | Cognitive Decline | BRCA1 Mutation | BRCA2 Mutation | Bone Mineral Density | Surgical Menopause | Menopause SurgicalNetherlands
-
National Cancer Institute (NCI)Terminated
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownMetastatic Castration Resistant Prostate Cancer
-
AstraZenecaCompletedOvarian CancerUnited Arab Emirates
-
AstraZenecaCompletedOvarian CancerBrazil, Panama, Colombia, Argentina, Mexico, Peru